Cutter & CO Brokerage, Inc. Ventyx Biosciences, Inc. Transaction History
Cutter & CO Brokerage, Inc.
- $393 Million
- Q1 2025
A detailed history of Cutter & CO Brokerage, Inc. transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 54,000 shares of VTYX stock, worth $74,520. This represents 0.02% of its overall portfolio holdings.
Number of Shares
54,000Holding current value
$74,520% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
132Shares Held
52.8MCall Options Held
63.4KPut Options Held
78.5K-
Black Rock Inc. New York, NY4.77MShares$6.58 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$6.18 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$5.9 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$5.58 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.85 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $78M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...